Alyeska Investment Group, L.P.

Position in JANX — Janux Therapeutics, Inc.

CIK 1453072 CHICAGO, IL

Position in JANX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$22,255,137

+$4,300,109 QoQ

Shares Held

1,601,089

+23.1% QoQ

Ownership

2.63%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Alyeska Investment Group, L.P. holds $1,219,709,732 across 81 Biotechnology names. JANX ranks #14 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	4,051,185	$205,800,198
2	RVMD	Revolution Medicines, Inc.	1,885,821	$183,396,092
3	JAZZ	Jazz Pharmaceuticals plc	411,015	$77,702,385
4	XENE	Xenon Pharmaceuticals Inc.	1,299,469	$75,564,122
5	PTGX	Protagonist Therapeutics, Inc	593,197	$62,522,963
6	DNLI	Denali Therapeutics Inc.	1,941,123	$37,269,561
7	IONS	Ionis Pharmaceuticals Inc	473,150	$35,528,833
8	TECH	BIO-TECHNE Corp	659,049	$34,441,900

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$22,255,137	1,601,089	+23.1%	Shares	Sole	2026-05-15
2025-12-31	$17,955,028	1,301,089	+206.3%	Shares	Sole	2026-02-13
2025-09-30	$10,383,211	424,845	+64.2%	Shares	Sole	2025-11-17
2025-06-30	$5,975,461	258,678	-36.7%	Shares	Sole	2025-08-14
2025-03-31	$11,034,306	408,678	+18.5%	Shares	Sole	2025-05-15
2024-12-31	$18,466,802	344,916	+69.8%	Shares	Sole	2025-02-14
2024-09-30	$9,230,649	203,184	+1.9%	Shares	Sole	2024-11-14
2024-06-30	$8,352,195	199,384	+3.3%	Shares	Sole	2024-08-14
2024-03-31	$7,268,181	193,046	-2.3%	Shares	Sole	2024-05-15
2023-12-31	$2,119,067	197,490	+12.9%	Shares	Sole	2024-02-14
2023-09-30	$1,764,000	175,000	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.